Correlation between tissue PD-L1, TMB, and blood PD-L1, MSI biomarkers in patients with advanced-stage non-small cell lung cancer (NSCLC).

被引：0
|
作者：
Nandimandalam, Sujitha
Sharma, Nitika
机构：
[1] East Carolina Univ, Greenville, NC 27858 USA
[2] East Carolina Univ, Vidant Canc Care, Greenville, NC 27858 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e21564
引用
收藏
页数：1
相关论文
共 50 条
  • [1] PD-L1 PET/CT Imaging with Radiolabeled Durvalumab in Patients with Advanced-Stage Non-Small Cell Lung Cancer
    Smit, Jasper
    Borm, Frank J.
    Niemeijer, Anna-Larissa N.
    Huisman, Marc C.
    Hoekstra, Otto S.
    Boellaard, Ronald
    Oprea-Lager, Daniela E.
    Vugts, Danielle J.
    van Dongen, Guus A. M. S.
    de Wit-van der Veen, Berlinda J.
    Thunnissen, Erik
    Smit, Egbert F.
    de Langen, Adrianus J.
    JOURNAL OF NUCLEAR MEDICINE, 2022, 63 (05) : 686 - 693
  • [2] PD-L1 Immunohistochemistry as Biomarker in Non-Small Cell Lung Cancer (NSCLC)
    Krenbek, Dagmar
    Weidinger, Barbara
    Jarius, Christa
    Holzer, Sophia
    Fabican, Hannah
    Mohn-Staudner, Andrea
    Hochmair, Maximilian
    Chott, Andreas
    Setinekl, Ulrike
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S430 - S430
  • [3] TMB, genetic alterations and PD-L1 expression in non-small cell lung cancer
    Gureviciene, Giedre
    Matulione, Jurgita
    Poskiene, Lina
    Miliauskas, Skaidrius
    Zemaitis, Marius
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [4] PD-L1 expression and genotype in Non-Small Cell Lung Cancer (NSCLC)
    Ansen, S.
    Schultheis, A.
    Hellmich, M.
    Leenders, F.
    Zander, T.
    Michels, S.
    Brockmann, M.
    Stoelben, E.
    Groen, H.
    Timens, W.
    Buettner, R.
    Thomas, R. K.
    Perner, S.
    Wolf, J.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 5 - 6
  • [5] PD-L1 expression and genotype in non-small cell lung cancer (NSCLC).
    Ansen, Sascha
    Schultheis, Anne Maria
    Hellmich, Martin
    Zander, Thomas
    Brockmann, Michael
    Stoelben, Erich
    Groen, Harry J. M.
    Timens, Wim
    Buettner, Reinhard
    Thomas, Roman K.
    Perner, Sven
    Wolf, Juergen
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [6] A Study on the Clinical Significance of Blood Exosomal PD-L1 in Non-Small Cell Lung Cancer Patients and its Correlation with PD-L1 in Tumor Tissues
    Cheng, Yonghong
    Chang, Feiyun
    Gong, Yanmei
    Lu, Ping
    HORMONE AND METABOLIC RESEARCH, 2023, 55 (11) : 788 - 793
  • [7] PD-1 and PD-L1 as immunotherapy targets and biomarkers in non-small cell lung cancer
    Tsoukalas, Nikolaos
    Kiakou, Maria
    Tsapakidis, Konstantinos
    Tolia, Maria
    Aravantinou-Fatorou, Eleni
    Baxevanos, Panagiotis
    Kyrgias, Georgios
    Theocharis, Stamatios
    JOURNAL OF BUON, 2019, 24 (03): : 883 - 888
  • [8] Biomarkers predictive of PD1/PD-L1 immunotheraphy in non-small cell lung cancer
    Lupo, A.
    Alifano, M.
    Wislez, M.
    Boulle, G.
    Velut, Y.
    Biton, J.
    Cremer, I.
    Goldwasser, F.
    Leroy, K.
    Damotte, D.
    REVUE DE PNEUMOLOGIE CLINIQUE, 2018, 74 (05) : 339 - 350
  • [9] Evaluate soluble PD-L1 in plasma in advanced stage non-small cell lung cancer patients
    Nhung Pham
    Quyet Do
    Thang Ta
    Dung Nguyen
    Dai Do
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [10] PD-L1 Expression in Patients with Non-small Cell Lung Cancer
    Masago, Katsuhiro
    Fujita, Shiro
    Hata, Akito
    Okuda, Chiyuki
    Kaji, Reiko
    Katakami, Nobuyuki
    Hirata, Yukio
    ANTICANCER RESEARCH, 2017, 37 (05) : 2269 - 2274
12345